Clinical Trials Browser

Terminated × INDUSTRY × Lymphoid Malignancies × Clear all

NCT02739360 2020-03-04

Roll Over Study to Provide Idelalisib to Participants Previously Treated With the Investigational PI3Kδ Inhibitor, GS-9820

Phase 4 Terminated

3 enrolled 5 charts

Lymphoid Malignancies

NCT01013818 2013-08-02

A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies

Phase 1 Terminated

Lymphoid Malignancies